UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (81) 81
life sciences & biomedicine (79) 79
oncology (72) 72
humans (66) 66
female (33) 33
aged (30) 30
male (30) 30
middle aged (28) 28
carcinoma, non-small-cell lung - drug therapy (24) 24
lung neoplasms - drug therapy (24) 24
immunotherapy (22) 22
lung cancer (22) 22
adult (21) 21
carcinoma, non-small-cell lung - pathology (20) 20
chemotherapy (20) 20
lung neoplasms - pathology (20) 20
care and treatment (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
neoplasm staging (18) 18
lung cancer, non-small cell (17) 17
cancer (16) 16
aged, 80 and over (15) 15
antibodies, monoclonal - therapeutic use (15) 15
antineoplastic agents - therapeutic use (14) 14
treatment outcome (14) 14
metastasis (13) 13
analysis (12) 12
respiratory system (12) 12
abridged index medicus (11) 11
antibodies, monoclonal - adverse effects (11) 11
cancer therapies (11) 11
non-small cell lung carcinoma (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
lung neoplasms - therapy (10) 10
mutation (10) 10
patients (9) 9
survival rate (9) 9
tumors (9) 9
antibodies, monoclonal - administration & dosage (8) 8
antineoplastic agents (8) 8
antineoplastic agents - adverse effects (8) 8
drug therapy (8) 8
hematology, oncology and palliative medicine (8) 8
prognosis (8) 8
research (8) 8
apoptosis (7) 7
carcinoma, non-small-cell lung - therapy (7) 7
disease-free survival (7) 7
nivolumab (7) 7
pembrolizumab (7) 7
antibodies, monoclonal, humanized - therapeutic use (6) 6
biomarkers (6) 6
carcinoma, non-small-cell lung - genetics (6) 6
chemistry (6) 6
cohort studies (6) 6
general & internal medicine (6) 6
immunotherapy - methods (6) 6
lung neoplasms - diagnosis (6) 6
lung neoplasms - genetics (6) 6
medicine, general & internal (6) 6
carcinoma, non-small-cell lung - diagnosis (5) 5
carcinoma, non-small-cell lung - mortality (5) 5
clinical trials (5) 5
ipilimumab (5) 5
lung neoplasms - mortality (5) 5
metallurgy (5) 5
monoclonal antibodies (5) 5
neoplasms - drug therapy (5) 5
non-small cell lung cancer (5) 5
nsclc (5) 5
organic chemistry (5) 5
original reports (5) 5
ovarian cancer (5) 5
patient outcomes (5) 5
pd-l1 protein (5) 5
peptides (5) 5
risk factors (5) 5
small cell lung carcinoma (5) 5
solid tumors (5) 5
animals (4) 4
antibodies, monoclonal, humanized - adverse effects (4) 4
antimitotic agents (4) 4
b7-h1 antigen - metabolism (4) 4
carcinoma, non-small-cell lung - metabolism (4) 4
cell survival (4) 4
ctla-4 antigen - antagonists & inhibitors (4) 4
disease progression (4) 4
docetaxel (4) 4
dosage and administration (4) 4
dose-response relationship, drug (4) 4
flow cytometry (4) 4
follow-up studies (4) 4
genetic aspects (4) 4
health aspects (4) 4
hematology (4) 4
human necessities (4) 4
hygiene (4) 4
ipilimumab - administration & dosage (4) 4
lung neoplasms - metabolism (4) 4
lymphomas (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 234 - 242
Journal Article
The New England journal of medicine, ISSN 1533-4406, 05/2018, Volume 378, Issue 22, pp. 2093 - 2104
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 08/2010, Volume 28, Issue 23, pp. 3701 - 3708
Purpose Interleukin-6 (IL-6) has emerged as a key factor in the pathogenesis of the atypical lymphoproliferative disorder Castleman's disease (CD). Siltuximab... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Young Adult | Castleman Disease - drug therapy | Humans | Middle Aged | Interleukin-6 - immunology | Adult | Antibodies, Monoclonal - therapeutic use | Female | Male | Aged | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2017, Volume 376, Issue 25, pp. 2415 - 2426
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2015, Volume 373, Issue 17, pp. 1627 - 1639
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2019, Volume 381, Issue 21, pp. 2020 - 2031
Patients with advanced non–small-cell lung cancer with a PD-L1 expression level of 1% or more of tumor cells were randomly assigned to receive nivolumab plus... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antineoplastic Agents, Immunological - administration & dosage | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Lung Neoplasms - metabolism | Middle Aged | Carcinoma, Non-Small-Cell Lung - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Ipilimumab - adverse effects | Nivolumab - adverse effects | Carcinoma, Non-Small-Cell Lung - mortality | Antineoplastic Agents, Immunological - adverse effects | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Ipilimumab - administration & dosage | Nivolumab - administration & dosage | Lung cancer, Non-small cell | Drug therapy | Patient outcomes | Ipilimumab | Testing | Small cell lung carcinoma | Lung cancer | Non-small cell lung carcinoma | Oncology | Cancer therapies | Chemotherapy | Immunotherapy | PD-L1 protein | Biomarkers | Clinical medicine | Mutation | Drug dosages | Apoptosis | Tumors | Index Medicus | Abridged Index Medicus | B7-H1 Antigen | Carcinoma, Non-Small-Cell Lung | Antineoplastic Combined Chemotherapy Protocols | Cellular Biology | Lung Neoplasms | Life Sciences | Antineoplastic Agents, Immunological | Nivolumab
Journal Article
Annals of oncology, ISSN 0923-7534, 10/2017, Volume 28 Suppl 9, p. ix20
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2009, Volume 15, Issue 18, pp. 5910 - 5916
Journal Article